Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The FDA approvals of 2010
Fierce Biotech
Wednesday, January 12, 2011 - 7:24pm
tags:
Watson Pharmaceuticals, Theratechnologies, Shire, Savient, Sanofi, Roche, Orphan Europe, Novo Nordisk, Novartis, Merz, JNJ, HRA Pharma, Genzyme, Forest Labs, FDA, Eisai, Dainippon Sumitomo, Chemiche Fabrik Kresussler, Boehringer Ingelheim, Bayer, Auxilium, Amgen, Allergan, Acorda Therapeutics
Biogen expects MS sales hit from Gilenya
Fierce Pharma
Wednesday, January 12, 2011 - 7:17pm
tags:
Biogen Idec, Gilenya, MS, multiple sclerosis
Lilly’s Solpura Isn’t Ready for Approval, Panel Says
Bloomberg
Wednesday, January 12, 2011 - 7:15pm
tags:
Eli Lilly, Solpura, advisory panels
Sanofi’s bid for Genzyme gets EU OK
Bizjournals.com
Wednesday, January 12, 2011 - 7:13pm
tags:
Genzyme, Sanofi, Europe, M&A
What Shorts Might Be Watching at Forest Laboratories
Motley Fool
Wednesday, January 12, 2011 - 12:34pm
tags:
Forest Labs
Allos reports $11.7 million in 4Q revenue
Yahoo/AP
Wednesday, January 12, 2011 - 12:34pm
tags:
earnings, Allos
Oregon Sues Johnson & Johnson Over ‘Phantom Recall’
Bloomberg
Wednesday, January 12, 2011 - 12:33pm
tags:
Oregon, JNJ, recalls, lawsuits
Lilly says brain swelling seen in Alzheimer's study patient
Reuters
Wednesday, January 12, 2011 - 12:24pm
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Sanofi, Genzyme Chiefs Say Talks Are Advancing on Fee
Bloomberg
Wednesday, January 12, 2011 - 12:18pm
tags:
Genzyme, Sanofi, M&A
Is XOMA a Turnaround Stock?
Seeking Alpha
Wednesday, January 12, 2011 - 12:17pm
tags:
Xoma
Illumina Strikes Back In Gene Machine Wars
Forbes
Wednesday, January 12, 2011 - 12:14pm
tags:
DNA sequencing, Illumina
Bayer ‘Determined’ to Guard Rights After Humira Ruling
Bloomberg
Wednesday, January 12, 2011 - 12:10pm
tags:
Bayer, Humira, Abbott Laboratories, arthritis
Is Biogen Idec's Stock a Bargain by the Numbers?
Motley Fool
Wednesday, January 12, 2011 - 12:08pm
tags:
Biogen Idec
Merck and Parexel Form Strategic Alliance
Bloomberg
Wednesday, January 12, 2011 - 12:07pm
tags:
Merck, Parexel, biosimilars, Merck BioVentures
A Clear Drug-Development Path -- Times 2
Motley Fool
Wednesday, January 12, 2011 - 12:06pm
tags:
drug development, Isis Pharmaceuticals, Genzyme, mipomersen
Painkillers May Raise Heart Attack, Stroke Risk, Review Says
Bloomberg
Wednesday, January 12, 2011 - 9:50am
tags:
heart attacks, stroke, Vioxx, painkillers, ibuprofen, naproxen, diclofenac
[video]Sanofi + Genzyme: Possible Deal?
Yahoo/CNBC
Wednesday, January 12, 2011 - 9:48am
tags:
Genzyme, Sanofi
Genzyme expects profit, revenue boost in 4th qtr
Yahoo/AP
Wednesday, January 12, 2011 - 9:47am
tags:
Genzyme, earnings
Amarin CEO Seeks Adviser After Buyer, Partner Interest
Bloomberg
Wednesday, January 12, 2011 - 9:46am
tags:
Amarin, M&A
Merck Vaccine Cuts Risk of Shingles by Half, Researchers Find
Bloomberg
Wednesday, January 12, 2011 - 9:45am
tags:
Merck, shingles, vaccines, Zostavax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.